Hypokalemic Periodic Paralysis
What's New
Last Posted: Mar 05, 2023
- PharmGKB summary: very important pharmacogene information for CACNA1S.
Sangkuhl Katrin, et al. Pharmacogenetics and genomics 2019 0 (2) 34-44 - Clinical and genetic spectrum of a Chinese cohort with SCN4A gene mutations.
Sun J, et al. Neuromuscular disorders : NMD 2021 0 (9) 829-838 - Thyrotoxic periodic paralysis associated with a mutation in the sodium channel gene SCN4A.
Lane Andrew H, et al. Journal of pediatric endocrinology & metabolism : JPEM 2005 0 (12) 1679-82 - Association study in Mexican patients with thyrotoxic hypokalemic periodic paralysis.
Bautista-Medina Mario Arturo, et al. Biomedical reports 2020 10 (4) 24 - Novel susceptibility gene for nonfamilial hypokalemic periodic paralysis.
Song I-Wen, et al. Neurology 2016 3 - Mutations of SCN4A gene cause different diseases: 2 case reports and literature review.
Liu Xiao-li, et al. Channels (Austin, Tex.) 2015 0 (2) 82-7 - Genetic variant rs623011 (17q24.3) associates with non-familial thyrotoxic and sporadic hypokalemic paralysis.
Chu Pei-Yi, et al. Clinica chimica acta; international journal of clinical chemistry 2012 12 105-8 - A genome-wide association study identifies novel susceptibility genetic variation for thyrotoxic hypokalemic periodic paralysis.
Jongjaroenprasert Wallaya, et al. Journal of human genetics 2012 5 (5) 301-4 - Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype.
Matthews E, et al. Neurology 2011 11 (22) 1960-4 - [The relationships between the single nueleotide polymorphisms of CACNA1S gene 11 exon and thyrotoxic hypokalemic periodic paralysis in the people of Han Nationality in Sichuan Province, China].
Xiao Zhu, et al. Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 2011 6 (3) 547-52, 558
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: